食品伙伴網(wǎng)訊  據(jù)歐盟食品安全局（EFSA）消息，10月30日歐盟食品安全局專(zhuān)家組就孟山都轉(zhuǎn)基因大豆MON 87705用于食品、飼料、進(jìn)口、加工發(fā)布了意見(jiàn)。

    歐盟食品安全局轉(zhuǎn)基因生物專(zhuān)家組認(rèn)為，在安全性方面轉(zhuǎn)基因大豆MON 87705同傳統(tǒng)大豆一樣，不會(huì)對(duì)人體、動(dòng)物的健康以及環(huán)境產(chǎn)生負(fù)面影響。

    部分原文報(bào)道如下：

    Following the submission of an application （EFSA-GMO-NL-2010-78） under Regulation （EC） No 1829/2003 from Monsanto, the Panel on Genetically Modified Organisms of the European Food Safety Authority （EFSA GMO Panel） was asked to deliver a scientific opinion on the safety of herbicide-tolerant, increased oleic acid genetically modified （GM） soybean MON 87705 （Unique Identifier MON-87705-6） for food and feed uses, import and processing.

    In delivering its scientific opinion, the EFSA GMO Panel considered the application EFSA-GMO-NL-2010-78, additional information supplied by the applicant, scientific comments submitted by the Member States and relevant scientific publications. The scope of application EFSA-GMO-NL-2010-78 is for food and feed uses, import and processing of soybean MON 87705 within the European Union as any non-GM soybean but excludes cultivation in the EU. The EFSA GMO Panel evaluated soybean MON 87705 with reference to the intended uses defined by the applicant and appropriate principles described in its Guidance Document of the Scientific Panel on Genetically Modified Organisms for the Risk Assessment of Genetically Modified Plants and Derived Food and Feed （EFSA, 2006a, 2011a）。 The applicant stated that the fatty acid properties of soybean MON 87705 oil would be suitable for replacement of liquid vegetable oils currently used in margarine, salad dressing, mayonnaise and spread, and home-use liquid oil. The applicant did not provide data which would allow a nutritional assessment of soybean MON 87705 oil when used for commercial frying （i.e. high-temperature and repeated frying）。 Therefore, the nutritional assessment of soybean MON 87705 oil performed by the GMO Panel in this Opinion excludes commercial frying.

    The scientific risk assessment included molecular characterisation of the inserted DNA, evaluation of the levels of the CP4 EPSPS protein and the increased oleic acid phenotype. An evaluation of the comparative analyses of composition, agronomic and phenotypic traits was undertaken, and the safety of the new proteins and the whole food/feed was evaluated with respect to potential toxicity, allergenicity and nutritional wholesomeness. An evaluation of the environmental impacts and the post-market environmental monitoring plan was undertaken.

    更多請(qǐng)見(jiàn)：http://www.efsa.europa.eu/en/efsajournal/pub/2909.htm